Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway

被引：0
|
作者：
Li, Chengyun [1 ]
Liang, Geyu [1 ]
Sui, Jing [1 ]
Yang, Sheng [1 ]
Xu, Siyi [1 ]
机构：
[1] Southeast Univ, Key Lab Environm Med Engn, Minist Educ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China
来源：
TOXICOLOGY LETTERS | 2017年 / 280卷
关键词：
D O I：
10.1016/j.toxlet.2017.07.663
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P-07-07-06
引用
收藏
页码：S239 / S240
页数：2
相关论文
共 50 条
  • [1] Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
    Li, Chengyun
    Liang, Geyu
    Yang, Sheng
    Sui, Jing
    Yao, Wenzhuo
    Shen, Xian
    Zhang, Yanqiu
    Peng, Hui
    Hong, Weiwei
    Xu, Siyi
    Wu, Wenjuan
    Ye, Yancheng
    Zhang, Zhiyi
    Zhang, Wenhua
    Yin, Lihong
    Pu, Yuepu
    ONCOTARGET, 2017, 8 (55) : 93476 - 93491
  • [2] LncRNA-LOC101928316 contributes to gastric cancer progression through regulating PI3K-Akt-mTOR signaling pathway
    Li, Chengyun
    Liang, Geyu
    Yang, Sheng
    Sui, Jing
    Wu, Wenjuan
    Xu, Siyi
    Ye, Yancheng
    Shen, Bo
    Zhang, Xiaomei
    Zhang, Yan
    CANCER MEDICINE, 2019, 8 (09): : 4428 - 4440
  • [3] CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
    Jiang, Chao
    Ma, Zhenghong
    Zhang, Guoan
    Yang, Xigui
    Du, Qin
    Wang, Weibo
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10135 - 10143
  • [4] PI3K-AKT-mTOR pathway and cancer
    Coutte, Laetitia
    Dreyer, Chantal
    Sablin, Marie-Paule
    Faivre, Sandrine
    Raymond, Eric
    BULLETIN DU CANCER, 2012, 99 (02) : 173 - 180
  • [5] GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling
    Yan, Guang
    Ru, Yi
    Wu, Kerong
    Yan, Fengqi
    Wang, Qinhao
    Wang, Jingxiang
    Pan, Tao
    Zhang, Mei
    Han, Hua
    Li, Xia
    Zou, Lian
    PROSTATE, 2018, 78 (03): : 166 - 177
  • [6] Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
    Yang, Dongyong
    Wang, Yanqing
    Zheng, Yajing
    Dai, Fangfang
    Liu, Shiyi
    Yuan, Mengqin
    Deng, Zhimin
    Bao, Anyu
    Cheng, Yanxiang
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [7] A bibliometric analysis of the application of the PI3K-AKT-mTOR signaling pathway in cancer
    Deng, Zhengzheng
    Qing, Qiancheng
    Huang, Bo
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (10) : 7255 - 7272
  • [8] Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
    Dongyong Yang
    Yanqing Wang
    Yajing Zheng
    Fangfang Dai
    Shiyi Liu
    Mengqin Yuan
    Zhimin Deng
    Anyu Bao
    Yanxiang Cheng
    Journal of Ovarian Research, 14
  • [9] Silencing of lncRNA UCA1 Reverses Doxorubicin Resistance of Breast Cancer Through Inhibiting PI3K/AKT/mTOR Signaling Pathway
    Suicmez, Menderes
    Namalir, Gamze
    Konus, Metin
    Ozdil, Hilal
    CHEMISTRYSELECT, 2024, 9 (20):
  • [10] The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors
    Saji, Motoyasu
    Ringel, Matthew D.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 321 (01) : 20 - 28
12345